Prophylaxie préexposition au VIH : efficace et sous-utilisée

This publication has 34 references indexed in Scilit:

• Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial
  The Lancet, 2016
• On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection
  New England Journal of Medicine, 2015
• A Brief Screening Tool to Assess the Risk of Contracting HIV Infection Among Active Injection Drug Users
  Journal of Addiction Medicine, 2015
• The High Risk of an HIV Diagnosis Following a Diagnosis of Syphilis: A Population-level Analysis of New York City Men
  Clinical Infectious Diseases, 2015
• Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study
  The Lancet Infectious Diseases, 2014
• HIV Incidence Among Men With and Those Without Sexually Transmitted Rectal Infections: Estimates From Matching Against an HIV Case Registry
  Clinical Infectious Diseases, 2013
• Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial
  The Lancet, 2013
• Antiretroviral Preexposure Prophylaxis for Heterosexual HIV Transmission in Botswana
  New England Journal of Medicine, 2012
• Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
  New England Journal of Medicine, 2012
• Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men
  New England Journal of Medicine, 2010